ArticlePloS one2026
Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Short- and Long-Term Outcomes of Pancreatic ERCP in Pre-Teens: A Swedish Single Center Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on long-term outcomes of endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic duct stones (PDS) in children with chronic pancreatitis (CP) remains scarce. This study aimed to evaluate the long-term clinical outcomes of ERCP in this population.
methodsA single-center retrospective cohort study was conducted on children with CP and PDS who underwent ERCP at our Hospital (2008.1.1-2024.12.31). Follow-up assessed stone clearance, complications, pain relief, pain type, growth, quality of life (QoL), and long-term complications.
resultsA total of 90 children with CP and PDS were enrolled in this single-center retrospective cohort study. ERCP achieved 72.1% complete stone clearance; overall complications were 9.6%. Among the 90 patients, 77 (85.6%) completed the full follow-up. Post-ERCP, all abdominal pain subtypes significantly decreased (P < 0.001), with 70.1% complete pain relief. Height and weight increased (P < 0.01); QoL (PedsQL™4.0) scores rose from 69 to 85 points (P < 0.001). Long-term complications included new diabetes (5.2%) and steatorrhea (5.2%); PDS recurrence was 7.8%.
conclusionERCP is safe and effective for children with CP and PDS, significantly improving long-term pain, growth, and QoL, supporting its role as a first-line therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.